Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes
Diagnostics · 09.03.2026 · 16 (5) · 810
DOI: 10.3390/diagnostics16050810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 09.03.2026. Verfasst von Răzvan Alexandru Marinescu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.
Abstract (Originalsprache)
Background/Objectives: Type 2 diabetes mellitus (T2DM) and atherogenic dyslipidemia have been implicated in colorectal cancer (CRC) development, but their prognostic relevance after cancer diagnosis remains unclear. This study aimed to evaluate the association between T2DM, lipid-derived atherogenic indices, and survival outcomes in patients with CRC.
Methods
We conducted a retrospective cohort study including 240 CRC patients, of whom 60 had coexisting T2DM. Overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan–Meier (KM) method and log-rank tests. In the absence of recurrence-specific data, DFS was defined as time to death or last follow-up. Lipid-related indices, including the atherogenic index of plasma (AIP), atherogenic coefficient (AC), remnant cholesterol (RC), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride–glucose (TyG) index, and triglyceride-to-HDL cholesterol ratio (TG/HDL-C), were evaluated by tertiles in KM analyses. Multivariable Cox proportional hazards models were constructed to assess the independent prognostic value of AIP, AC, and RC (entered separately as a continuous variable standardized to 1 standard deviation), adjusted for age, sex, adjuvant chemotherapy, radiotherapy, and T2DM status. Sensitivity analyses were performed in stage III–IV patients.
Results
During follow-up, 28 deaths occurred. OS did not differ significantly between CRC patients and those with CRC coexisting with T2DM (log-rank p-values = 0.220). DFS analyses showed no significant differences across tertiles of any lipid-related index (all log-rank p-values > 0.05), with overlapping survival curves and no consistent dose–response patterns. In adjusted Cox models, AIP (hazard ratio [HR] per 1 SD = 0.71, 95% CI 0.48–1.06), AC (HR = 0.72, 95% CI 0.44–1.20), and RC (HR = 0.66, 95% CI 0.39–1.12) were not independently associated with DFS. Results were consistent in advanced-stage disease (stage III–IV).
Conclusions
In this cohort of patients with CRC, neither T2DM nor lipid-derived indices reflecting atherogenic dyslipidemia and insulin resistance were independently associated with OS or DFS. These findings help refine the clinical interpretation of lipid-derived biomarkers in CRC, suggesting limited prognostic utility beyond established oncologic factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Oncology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Surgery, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.
- Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
ORCID-Profile: Lidia Boldeanu, Ana-Maria Ciurea, Petrica Popa, Mohamed-Zakaria Assani, Mihail Virgil Boldeanu, Valeriu Șurlin
Förderung
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Marinescu, R. A., Marinescu, D., Boldeanu, L., Ciurea, A. M., Bică, M., Pătrașcu, Ș., Strâmbu, V. D. E., Radu, P. A., Popa, P., Assani, M. Z., Boldeanu, M. V., & Șurlin, V. (2026). Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes. Diagnostics, 16(5), 810. https://doi.org/10.3390/diagnostics16050810
Vancouver
Marinescu RA, Marinescu D, Boldeanu L, Ciurea AM, Bică M, Pătrașcu Ș, et al. Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes. Diagnostics. 2026;16(5):810. doi:10.3390/diagnostics16050810
BibTeX
@article{Marinescu2026,
author = {Marinescu, Răzvan Alexandru and Marinescu, Daniela and Boldeanu, Lidia and Ciurea, Ana-Maria and Bică, Marius and Pătrașcu, Ștefan and Strâmbu, Victor Dan Eugen and Radu, Petru Adrian and Popa, Petrica and Assani, Mohamed-Zakaria and Boldeanu, Mihail Virgil and Șurlin, Valeriu},
title = {Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {5},
pages = {810},
doi = {10.3390/diagnostics16050810}
}
EUVIMED